Review of meningococcal group B vaccines.

Review of meningococcal group B vaccines.
复制标题

DOI:
10.1086/648966
复制
发表时间:
2010-03-01
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
通讯作者:
Granoff DM
Granoff DM
中科院分区:
其他
文献类型:
--
作者:
Granoff DM

文献摘要

参考文献

被引文献

相似文献

没有广泛有效的疫苗可用于预防B群脑膜炎球菌病,这类疾病占所有病例的50%以上。组B胶囊是一种自身抗原,不是合适的疫苗靶标。外膜囊泡(OMV)疫苗似乎是安全和有效的,但婴儿的血清杀菌(SBA)反应是特异性的孔蛋白(PorA),这是抗原可变的。为了扩大保护,已经从多于1个菌株;从具有多于1个PorA的突变体;或具有遗传脱毒的内毒素和过表达的期望抗原如因子H结合蛋白(fHbp)的突变体制备OMV疫苗。此外,重组蛋白疫苗如fHbp,单独或与其他抗原联合给药,处于临床开发后期,可能对大多数B组菌株有效。因此,开发预防脑膜炎球菌病(包括B群菌株)的疫苗的前景从未如此美好。
No broadly effective vaccines are available for prevention of group B meningococcal disease, which account for > 50% of all cases. The group B capsule is an autoantigen and is not a suitable vaccine target. Outer-membrane vesicle (OMV) vaccines appear to be safe and effective but serum bactericidal (SBA) responses of infants are specific for a porin protein (PorA), which is antigenically variable. To broaden protection, OMV vaccines have been prepared from more than 1 strain; from mutants with more than 1 PorA; or mutants with genetically detoxified endotoxin and overexpressed desirable antigens such as factor H-binding protein (fHbp). Also, recombinant protein vaccines such as fHbp, given alone or combined with other antigens, are in late-stage clinical development and may be effective against the majority of group B strains. Thus, the prospects have never been better for developing vaccines for prevention of meningococcal disease, including group B strains.
DOI: 10.1016/0264-410x(96)00020-5
发表时间: 1996-07-01
期刊: VACCINE
影响因子: 5.5
作者:
Claassen, I;Meylis, J;Poolman, J
通讯作者: Poolman, J
纳达(Nada),奈瑟氏菌脑膜炎的新型疫苗候选者。
DOI: 10.1084/jem.20020407
发表时间: 2002-06-03
影响因子: 15.3
作者:
Comanducci, Maurizio;Bambini, Stefania;Brunelli, Brunella;Adu-Bobie, Jeannette;Arico, Beatrice;Capecchi, Barbara;Giuliani, Marzia Monica;Masignani, Vega;Santini, Laura;Savino, Silvana;Granoff, Dan M;Caugant, Dominique A;Pizza, Mariagrazia;Rappuoli, Rino;Mora, Marirosa
通讯作者: Mora, Marirosa
DOI: 10.1086/597806
发表时间: 2009-05-01
影响因子: 6.4
作者:
Beernink, P. T.;Caugant, D. A.;Granoff, D. M.
通讯作者: Granoff, D. M.
DOI: 10.1016/j.vaccine.2005.06.011
发表时间: 2005-10-17
期刊: VACCINE
影响因子: 5.5
作者:
Cox, AD;Zou, W;Richards, JC
通讯作者: Richards, JC
DOI: 10.1046/j.1440-1754.2001.00722.x
发表时间: 2001-10-01
影响因子: 1.7
作者:
Baker, M G;Martin, D R;Lennon, D
通讯作者: Lennon, D